Related by context. All words. (Click for frequent words.) 73 euthymic patients 68 comorbid disorders 68 syndromal 67 comorbid depression 67 depressive disorders 67 dysthymia 66 dysthymic disorder 66 psychiatric comorbidities 66 depressive episodes 66 chronicity 65 subsyndromal 65 psychotic disorders 65 affective psychosis 65 nonpsychotic 65 affective disorders 65 depressive disorder 65 Major depressive disorder 65 affective disorder 65 alexithymia 65 somatic symptoms 65 hypochondriasis 64 neurocognitive impairment 64 extrapyramidal symptoms 64 Anxiety disorders 64 dissociative disorders 64 psychiatric disorders 63 bulimia nervosa 63 Pathological gambling 63 somatoform disorders 63 Major Depressive Disorder 63 suicide attempters 63 clozapine Clozaril 63 psychiatric morbidity 63 depressive symptomatology 63 typical antipsychotics 63 comorbidity 63 somatic complaints 63 depressive episode 63 emotional lability 63 nondepressed 63 hypomanic symptoms 62 psychiatric comorbidity 62 attention-deficit/hyperactivity disorder ADHD 62 bipolar illness 62 dyslipidaemia 62 schizophrenia schizoaffective disorder 62 juvenile idiopathic arthritis JIA 62 risperidone Risperdal 62 major depressive disorder 62 affective psychoses 62 DSM IV diagnosis 62 Comorbid 62 quetiapine Seroquel 62 neuroleptic 62 serotonin reuptake inhibitors 62 Cognitive impairment 61 bipolar disorders 61 underdiagnosis 61 Personality disorders 61 TEAEs 61 unprovoked seizures 61 citalopram 61 generalized anxiety disorder GAD 61 generalized epilepsy 61 narcolepsy cataplexy 61 venlafaxine Effexor 61 Atypical antipsychotics 61 externalizing disorders 61 SRBD 61 neuropsychiatric disorder 61 schizophrenia 61 euthymic 61 diarrhea predominant IBS 61 atherothrombotic disease 61 MGUS 61 Generalized Anxiety Disorder 61 neuropsychiatric symptoms 61 premenstrual dysphoric disorder 61 tic disorders 61 T1DM 61 schizophrenia CIAS 61 #q#.# deletion syndrome 61 comorbid 61 Antisocial Personality Disorder 61 neuroleptics 61 DSM IV Axis 60 comorbid psychiatric 60 psychiatric diagnoses 60 Tourette syndrome TS 60 venlafaxine XR 60 Mood disorders 60 VaD 60 conventional antipsychotics 60 neuropsychological deficits 60 systemic lupus erythematosus SLE 60 OSAHS 60 prodromal 60 comorbid anxiety 60 antiepileptic drugs AEDs 60 subclinical hypothyroidism 60 familial aggregation 60 probands 60 sub syndromal 60 elevated serum creatinine 60 dopamine receptor gene 60 psychosocial functioning 60 clomipramine 60 fluoxetine Prozac 60 depression suicidal ideation 60 antiepileptics 60 autonomic dysfunction 60 paroxetine Paxil 60 ziprasidone Geodon 60 tricyclic antidepressant 60 shorter telomere length 60 bipolar depression 60 prodromal symptoms 60 Wernicke Korsakoff syndrome 60 bipolar disorder manic depression 60 androgen deficiency 60 haloperidol Haldol 60 predisposing factor 60 SGAs 60 tricyclic antidepressants 60 APOE ε4 60 neuropsychological impairments 60 behavioral disinhibition 60 T2DM 60 Index CDAI 59 symptomatology 59 pediatric bipolar disorder 59 oxcarbazepine 59 ziconotide 59 comorbid conditions 59 C1 INH deficiency 59 schizoaffective disorders 59 acamprosate 59 ADPKD 59 tranylcypromine 59 familial pancreatic cancer 59 premenstrual syndrome PMS 59 depressive symptom 59 sertraline Zoloft 59 Suicidal ideation 59 poststroke 59 neurological abnormalities 59 generalized anxiety disorder 59 overactive bladder symptoms 59 puerperal psychosis 59 dementia praecox 59 hyperactivity impulsivity 59 serotonin reuptake inhibitors SSRIs 59 suicidal ideation 59 schizotypal traits 59 aldosterone antagonist 59 psychiatric outpatients 59 Social Phobia 59 acute mania 59 PsA 59 Paxil paroxetine 59 adjunctive placebo 59 HIV HCV coinfected 59 schizophreniform disorder 59 monozygotic twin 59 generalized tonic clonic seizures 59 hypoperfusion 59 nonadherence 59 macroalbuminuria 59 psychotic illnesses 59 bipolar affective disorder 59 partial onset seizures 59 subclinical hyperthyroidism 59 serotonin reuptake inhibitor 59 dysphoric 59 internalizing disorders 59 #q# deletion syndrome 59 migraineurs 59 Heritability 59 akathisia 59 Neuroticism 59 systolic hypertension 59 hypersomnia 59 anticonvulsants 59 hepatitis C genotype 59 astrocytomas 59 hepatic encephalopathy HE 59 juvenile idiopathic arthritis 58 DPNP 58 thromboembolic complications 58 mental disorders 58 quetiapine risperidone 58 cerebral microbleeds 58 mood disorders 58 MADRS score 58 rufinamide 58 CP CPPS 58 Abilify aripiprazole 58 hyperkinetic disorder 58 interpersonal psychotherapy 58 tonic clonic seizures 58 obsessive compulsive disorder OCD 58 nonalcoholic steatohepatitis NASH 58 borderline personality disorder 58 symptom severity 58 Lamotrigine 58 opioid dependent 58 atypical antipsychotic medications 58 abnormal lipid 58 psychotic symptoms 58 Oppositional Defiant Disorder 58 fluoxetine paroxetine 58 antiepileptic medications 58 depressive episodes associated 58 subclinical atherosclerosis 58 adjunctive ABILIFY 58 mood dysregulation 58 MMSE scores 58 divalproex sodium 58 diabetes mellitus DM 58 HeFH 58 lipid abnormalities 58 sertraline 58 memantine Namenda 58 hypomanic episodes 58 metabolic disturbances 58 premorbid 58 Replication NCS R 58 compulsive hoarding syndrome 58 hematopoietic cancers 58 multivariate analyzes 58 PMDD 58 neuroleptic drugs 58 RLAI 58 tricyclics 58 lipid lowering agents 58 left ventricular dysfunction 58 parkinsonism 58 hyperalgesia 58 substance induced psychosis 58 elevated ALT 58 pharmacologic treatments 58 chronic rhinosinusitis 58 habitual snoring 58 rheumatic disorders 58 thyrotropin levels 58 Serious adverse reactions 58 ALT flares 58 citalopram Celexa 58 vWD 58 migraine prophylaxis 58 hyperreflexia 58 idiopathic PAH 58 macrovascular disease 58 MCyR 58 Posttraumatic stress disorder PTSD 58 schizoaffective disorder 58 manic depressive illness 58 atherogenic dyslipidemia 58 antihypertensive therapy 58 subthreshold 57 Bipolar Mania 57 syncopal 57 behavioral abnormalities 57 paroxysmal AF 57 androgen excess 57 relapsed MM 57 mania hypomania 57 osteosarcomas 57 overactive bladder syndrome 57 dysglycemia 57 agomelatine 57 neuropsychological functioning 57 Depressive symptoms 57 cryptogenic 57 polyarticular 57 Sociodemographic 57 IBS C 57 ataxias 57 Interpersonal psychotherapy 57 LUTS 57 perimenopausal women 57 premenstrual dysphoric disorder PMDD 57 anterior uveitis 57 hyperactive impulsive 57 transaminase elevations 57 diastolic hypertension 57 disorder FSAD 57 TMS Therapy 57 carotid stenosis 57 nortriptyline Pamelor 57 5 HTTLPR 57 psychiatric disorder 57 primary generalized tonic 57 quetiapine 57 Duloxetine 57 Lu AA# 57 genetic loci 57 histologic subtypes 57 neurologic complications 57 Obsessive compulsive disorder 57 INVEGA ® 57 thrombophilia 57 atopic eczema 57 Obsessive compulsive disorder OCD 57 lamotrigine 57 cerebral infarction 57 epilepsies 57 Prehypertension 57 Antidepressant medications 57 VADT 57 psychotic illness 57 manic hypomanic 57 nondemented 57 Allergic rhinitis 57 hypertensives 57 induce orthostatic hypotension 57 ziprasidone 57 EoE 57 vasomotor symptoms 57 depressive symptoms 57 idiopathic Parkinson disease 57 aripiprazole Abilify 57 Primary IGFD 57 chronic prostatitis 57 antiandrogens 57 tricyclic antidepressants TCAs 57 atypicals 57 cholinesterase inhibitor 57 elevated triglyceride levels 57 baseline HbA1c 57 Rheumatoid Arthritis RA 57 heterozygous familial 57 SSRI SNRI 57 subtrochanteric 57 bipolar disorder schizophrenia 57 MMSE score 57 hypoglycemic events 57 neuropsychiatric diseases 57 dopaminergic therapy 57 generalized seizures 57 poststroke depression 57 somatization 57 Mental Disorders Fourth 57 serum urate levels 57 neurocognitive deficits 57 chronic opioid 57 serous ovarian cancer 57 HPA axis 57 OAB symptoms 57 AUDs 56 Severe Primary IGFD 56 trials RCTs 56 Electroconvulsive therapy 56 postoperative delirium 56 episodic migraine 56 CR nPR 56 5 HT1A 56 pharmacotherapies 56 etiologies 56 urinary incontinence UI 56 opioid naïve 56 etiological factors 56 irritable bowel syndrome IBS 56 nonpsychiatric 56 untreated celiac disease 56 haematologic 56 SSRI antidepressant 56 posttraumatic stress disorder PTSD 56 white matter hyperintensities 56 neurocognitive functioning 56 GABRA2 56 urolithiasis 56 newer antipsychotics 56 SJIA 56 Comorbidity 56 THIS STUDY 56 osteoporotic vertebral fractures 56 familial adenomatous polyposis 56 nulliparous women 56 anticonvulsant medications 56 schizotypal personality disorder 56 GH deficiency 56 retrospective cohort 56 Sjögren syndrome 56 placebo controlled trials 56 neurological manifestations 56 Major Depressive Disorder MDD 56 bipolar disorder 56 paliperidone ER 56 compulsive hoarding 56 prescribed antipsychotics 56 antidepressants antipsychotics 56 polycystic ovary syndrome PCOS 56 polysubstance abuse 56 Relapsing remitting MS 56 Psychiatric Disorders 56 comorbid ADHD 56 Y BOCS 56 Bulimia Nervosa 56 RLS symptoms 56 gastroesophageal reflux GERD 56 eating disorders anorexia nervosa 56 subscale scores 56 cardioembolic stroke 56 myeloproliferative neoplasms 56 psychopathological symptoms 56 BMI z 56 recurrent miscarriage 56 comorbid substance 56 hypomania 56 recurrent VTE 56 glitazones 56 Binge eating 56 parasomnias 56 amisulpride 56 newer atypical antipsychotics 56 schizoid personality disorder 56 salmeterol HFA MDI 56 CIMZIA ™ 56 dissociative symptoms 56 coinfected patients 56 norepinephrine reuptake inhibitor 56 cytogenetic response 56 psychiatric inpatients 56 primary Restless Legs 56 Suicidal thoughts 56 eosinophilic asthma 56 proband 56 Postnatal depression 56 comorbidities 56 complement inhibitor eculizumab 56 Schizophrenics 56 CCyR 56 ragweed allergic 56 Parnate 56 psychiatric illnesses 56 autoantibody positive 56 Schizoaffective Disorder 56 chlamydial infection 56 hypertriglyceridemia 56 neurologic symptoms 56 monogenic 56 hyperprolactinemia 56 ischemic cardiomyopathy 56 anticholinergics 56 depression 56 Alzheimer disease vascular dementia 56 somatization disorder 56 NMDA receptor antagonists 56 internalizing behaviors 56 steatohepatitis 56 inattention hyperactivity 56 Selective Serotonin Reuptake Inhibitors 56 Juvenile Idiopathic Arthritis JIA 56 aneurysmal subarachnoid hemorrhage 56 urinary symptoms 56 uncontrolled asthma 56 psychodynamic therapy 56 histological subtype 56 Vitamin B# deficiency 56 NAFLD 56 Ménière disease 56 oxycodone CR 56 schizotypal 56 abstinent alcoholics 56 depressive illness 56 acute leukemias 56 CRF1 receptor 56 dyspareunia 56 BPH LUTS 56 RLS sufferers 56 prostate cancer CaP 56 coprolalia 56 neuroblastomas 56 gastro esophageal reflux 56 reboxetine 56 maladaptive behaviors 56 asymptomatic PAD 56 nontraumatic 56 antiepileptic drugs 56 atrophic gastritis 56 periprocedural MI 56 MIRAPEX 56 univariate analyzes 56 nonmelanoma skin cancers 56 hypoactive 56 Excessive daytime sleepiness 56 stress cardiomyopathy 56 manic depression bipolar disorder 56 CIMZIA TM certolizumab pegol 56 hyper IgE syndrome 56 CIN3 56 Mental disorders 56 MDD 56 depression schizophrenia bipolar 56 metabolic abnormalities 56 neuroimaging studies 56 paragangliomas 55 oppositional defiant disorder 55 premature ejaculation PE 55 airway hyperresponsiveness 55 endophenotypes 55 diabetic neuropathic pain 55 Bronchiectasis 55 rhinosinusitis 55 neuropsychiatric disorders 55 Premenstrual Dysphoric Disorder 55 cytogenetic responses 55 prucalopride 55 coronary stenoses 55 vesicoureteral reflux 55 aspartate aminotransferase AST 55 schizophrenics 55 extrapyramidal disorder 55 pimozide 55 Childhood Disorder 55 #HT#A 55 Conduct Disorder 55 anticholinergic drugs 55 hypertension diabetes mellitus 55 autistic traits 55 bivariate analyzes 55 neurodevelopmental disorder 55 dopamine antagonists 55 Cognitive dysfunction 55 prostatic hyperplasia 55 #q# deletion 55 pulmonary hypertension PH 55 anxiolytic 55 intracranial hypertension 55 atypical neuroleptics 55 androgen depletion 55 KRAS mutations occur 55 morphometric vertebral fractures 55 Chronic ITP 55 posttraumatic stress disorder 55 Effexor venlafaxine 55 Montgomery Åsberg Depression 55 depressive illnesses 55 serotonin norepinephrine reuptake inhibitors 55 COPD exacerbation 55 covariate 55 non aspirin NSAIDs 55 progressive neurodegenerative disorder 55 canakinumab 55 serum IGF 55 diagnosable mental illness 55 confusional 55 Nicotine dependence 55 lymphoproliferative disorder 55 diagnosable disorder 55 hormonal abnormalities 55 STEP BD 55 neurodevelopmental disability 55 paroxetine sertraline 55 knee osteoarthritis OA 55 tryptophan depletion 55 HER2 overexpression 55 reuptake inhibitors 55 dysuria 55 Psychiatric disorders 55 reuptake inhibitor 55 symptomatic BPH 55 depression suicidality 55 primidone 55 onset seizures 55 SCIg 55 familial clustering 55 Autistic Disorder 55 Psychotic depression 55 Tardive dyskinesia 55 medically refractory 55 suicide ideation 55 myofascial pain syndrome 55 constipation OIC 55 basal cell nevus syndrome 55 Hypoactive Sexual Desire Disorder 55 aminotransferase levels 55 ADHD symptoms 55 hypovitaminosis D 55 laboratory abnormalities 55 Intervention Effectiveness CATIE 55 multi infarct dementia 55 angiotensin receptor blockers ARBs 55 SGPT 55 VUR 55 β blockers 55 retinal vein occlusion 55 hyperglycaemia 55 depression generalized anxiety 55 Haptoglobin 55 sarcomatoid 55 anemia hemoglobin 55 NESARC 55 acute gout 55 hypercalcemia 55 somatostatin analog 55 Topiramate 55 placebo controlled clinical trials 55 Neovascular AMD 55 System IPSS 55 histologic subtype 55 atopic 55 hypomanic 55 MGd 55 autoimmune thyroid 55 aortic atherosclerosis 55 valproate 55 DQB1 * 55 onset diabetes mellitus 55 paroxetine 55 antidepressant therapy 55 NOMID 55 primary hypercholesterolemia 55 arterial thromboembolic events 55 asthma rhinitis 55 selective serotonin reuptake inhibitor 55 cytopenia 55 antenatal depression 55 adverse cytogenetics 55 undergoing CABG 55 diagnosable mental disorder 55 asthma exacerbations 55 plasma creatinine 55 Irritable bowel syndrome 55 aminotransferases 55 subsyndromal depression 55 nociceptive pain 55 logistic regression model 55 hamartomas 55 antipsychotics 55 paroxysmal atrial fibrillation 55 proliferative diabetic retinopathy 55 essential thrombocythemia 55 HBeAg positive 55 RRMS patients 55 atherothrombotic 55 sociodemographic variables 55 Chronic pancreatitis 55 recurrent venous thromboembolism 55 % CI #.#-#.# [008] 55 cardiac dysfunction 55 neurosensory 55 tocilizumab 55 neurologic dysfunction 55 loop diuretics 55 acetabular dysplasia 55 biologic therapy 55 HIV lipodystrophy 55 neurodevelopmental outcome 55 neuropathologic 55 abdominal adiposity 55 attain statistical significance 55 plasma folate 55 chronic periodontitis 55 schizophrenia bipolar disorder 55 myoclonus 55 concomitant AEDs 55 generalized anxiety 55 Secondhand smoke exposure 55 psychiatric hospitalization 55 proliferative retinopathy 55 SNRIs 55 Comorbidities 55 impaired glucose metabolism 55 Prozac fluoxetine 55 neurobehavioral disorder 55 Adjuvant chemotherapy 55 chlorpromazine 55 Generalized Anxiety Disorder GAD 55 APTIVUS r 55 acute coronary syndromes ACS 55 fetal malformations 55 Borderline personality 55 TNF antagonist 55 monoamine oxidase inhibitors 55 Chronic fatigue 55 AGILECT ® 55 perioperative complications 55 histologically confirmed 55 TMP SMX 55 arterial thickening 55 mild cognitive impairments 55 systemic corticosteroid 55 neurodevelopmental impairment 55 Parkinsonian Syndromes 55 Heavy menstrual bleeding 55 psychopathology 55 Parkinson disease PD 55 MetS 55 EXJADE 55 chronic idiopathic 55 TT genotype 55 Zoloft sertraline 55 corticosteroid therapy 55 Nonspecific 55 non metastatic osteosarcoma 55 HBeAg negative patients 55 Posttraumatic Stress Disorder PTSD 55 peritumoral brain edema 55 opioid naive 55 virological response 55 autism Asperger Syndrome 55 Luvox fluvoxamine 55 myeloproliferative diseases 55 Sydenham chorea 55 clobazam 55 pain syndromes 55 Juvenile Idiopathic Arthritis 55 antidepressant efficacy 55 amnestic MCI 55 Chronic constipation 54 pyridostigmine 54 atypical hyperplasia 54 methodological limitations 54 HAMD 54 thyrotropin 54 Erythropoietic therapies may 54 acne vulgaris 54 body dysmorphic disorder 54 systolic dysfunction 54 prevalences 54 postoperative atrial fibrillation 54 gastric cardia 54 hyperammonemia 54 paroxysmal 54 etiologic 54 symptomology 54 carcinoid 54 grade cervical intraepithelial 54 hypercoagulable 54 K ras mutations 54 neurological disorder affecting 54 invasive candidiasis 54 psychostimulants 54 PGTC seizures 54 Attention-Deficit/Hyperactivity Disorder ADHD 54 AA Amyloidosis 54 diabetes dyslipidemia 54 familial hypercholesterolemia 54 chronic pancreatitis 54 corticosteroid dose 54 placebo controlled clinical 54 reflux symptoms 54 fluvoxamine 54 comorbid psychiatric disorders 54 Osteoarthritis OA 54 electroencephalographic 54 Crohn Disease Activity 54 frontotemporal dementia 54 cardiovascular comorbidities 54 Psychotic Disorders 54 progressive neurologic 54 tipranavir ritonavir 54 detrusor overactivity 54 neoadjuvant radiation 54 ADCS CGIC 54 hypoglycemic episodes 54 Inflammatory bowel disease 54 chromosome #q#.# [001] 54 refractory epilepsy 54 suppurative 54 idiopathic generalized epilepsy 54 immunodeficiencies 54 allodynia 54 congenital malformations 54 nocturnal enuresis 54 impaired cognition 54 somnolence sedation 54 binge eating disorders 54 mu opioid 54 deletion 5q 54 Selective Serotonin Reuptake Inhibitor 54 glycated hemoglobin levels 54 MYCN amplification 54 bronchopulmonary dysplasia BPD 54 hypoglycaemic episodes 54 Tourette Syndrome TS 54 neurogenic bladder 54 Korsakoff syndrome 54 variceal bleeding 54 intravenous bisphosphonates 54 Ankylosing spondylitis 54 Celexa citalopram 54 anxiety disorders 54 EURIDIS 54 histologies 54 GISTs 54 ADHD 54 somnolence dizziness 54 #q#.# [001] 54 infliximab Remicade 54 systemic lupus erythematosus 54 fatal anaphylactic 54 chronic urticaria 54 hereditary predisposition 54 Antipsychotics 54 Prostatitis 54 serum estradiol 54 Allergic Rhinitis 54 chronic immune thrombocytopenic 54 esophageal squamous cell carcinoma 54 CYT# potent vascular disrupting 54 angiotensin II receptor blockers 54 EDNOS 54 neuropsychological impairment 54 HNPCC 54 adenotonsillectomy 54 posterior cingulate 54 Serdolect 54 uncontrolled seizures 54 neurobiological disorder 54 elevated CRP 54 Zoloft Paxil 54 sCJD 54 Premature ejaculation 54 Atomoxetine 54 dysmenorrhoea 54 gestational diabetes mellitus 54 PTEN mutations 54 seminomas 54 imipramine 54 hypoparathyroidism 54 nonhereditary 54 PNH patients 54 histrionic personality 54 psychiatric disorders ATI 54 trastuzumab Herceptin ® 54 hippocampal volumes 54 recurrent glioblastoma multiforme 54 epithelial tumors 54 chlorambucil 54 tic disorder 54 Irritable Bowel Syndrome IBS 54 leukotriene receptor antagonists 54 eplerenone 54 Treatment Resistant 54 post transplant lymphoproliferative 54 myeloproliferative 54 avoidant personality disorder 54 Zeldox 54 tiagabine 54 IPAH 54 rhinoconjunctivitis 54 covariates 54 serotonin neurotransmission 54 ADHF 54 LV dysfunction 54 follicular lymphoma FL 54 Akathisia 54 Bacterial vaginosis 54 Selective Serotonin Re 54 underwent CABG 54 subconjunctival hemorrhage 54 Schizophrenia 54 non alcoholic steatohepatitis 54 alanine aminotransferase ALT 54 Flu Cy 54 AVODART 54 C. difficile colitis 54 testosterone supplementation 54 psychosis 54 borderline personality disorders 54 AAT deficiency 54 hematologic toxicity 54 operable breast cancer 54 tamoxifen Nolvadex ® 54 DRD2 54 chronic migraine 54 Asperger disorder 54 parkinsonian symptoms 54 poor metabolizers 54 Doxil ® 54 fibromyalgia syndrome 54 tegaserod 54 post thrombotic syndrome 54 MAGE A3 ASCI 54 rheumatic disease 54 olanzapine quetiapine 54 upper airway obstruction 54 cognitive impairment associated 54 mixed hyperlipidemia 54 lymphocytic 54 duloxetine Cymbalta 54 malperfusion 54 Attention Deficit Hyperactive Disorder 54 bosentan 54 Kraepelin 54 autism spectrum disorders ASDs 54 de novo AML 54 Torsades de Pointes 54 EEG abnormalities 54 dysmenorrhea 54 IL 1ß 54 mood swings irritability 54 infarctions 54 menopausal symptom 54 autosomal dominant disorder 54 TMC# r 54 long acting bronchodilator 54 refractory anaplastic astrocytoma 54 hypercalciuria 54 non affective psychosis 54 divalproex 54 onset atrial fibrillation 54 refractory gout 54 #mg/day [001] 54 NeuroStar TMS Therapy 54 motor tics 54 AGILECT R 54 primary dysmenorrhoea 54 Diabetic peripheral neuropathy 54 pharmacologic therapies 54 NATRECOR R 54 muscle dysmorphia 54 Pervasive Developmental Disorder 54 chronic renal insufficiency 54 psychosis schizophrenia 54 frequent awakenings 54 postmenopausal hormone 54 hippocampal atrophy 54 beta blocker therapy 54 Leukemias 54 DSM IV criteria 54 VIIBRYD 54 thyrotoxicosis 54 premenstrual symptoms 54 carotid IMT 54 NATRECOR ® 54 lichen planus 54 Antipsychotic drugs 54 ARICEPT 54 leukemia AML 54 ethosuximide 54 sulphonylureas 54 adolescent females 54 colorectal adenomas 54 gouty arthritis 54 Hashimoto thyroiditis 54 airflow obstruction 54 HBeAg negative 54 HMG CoA reductase inhibitors 54 cholinergic tone 54 childhood acute lymphoblastic 54 musculoskeletal pain 54 neuroinflammatory 54 neuropathies 54 microdeletion 54 remitting MS 54 psychotherapies 54 pentoxifylline 54 YMRS 54 hemodynamically significant 54 relapsing remitting 54 T2 lesions 54 Bipolar disorder 54 cranial irradiation 54 decompensated liver disease 54 confounder 54 visilizumab 54 anti epileptics 54 HAM D# 54 methotrexate monotherapy 54 infarcts 54 atherothrombosis 54 HRQL 54 Cariprazine 54 GBA mutations 54 S. aureus isolates 54 Schizophrenia affects 54 activity MAOA 54 aripiprazole 54 Chronic insomnia 54 homozygous familial hypercholesterolemia 54 susceptibility loci 54 PPAR gamma agonists 54 paliperidone palmitate 54 beta carotene supplementation 54 imipramine Tofranil 54 olfactory dysfunction 54 octreotide LAR 54 serum retinol 54 opiate dependence 54 prospectively enrolled 54 neurosteroid 54 G6PD deficiency 54 silent myocardial ischemia 54 Fibromyalgia Syndrome FMS 54 clozapine 54 venlafaxine 54 convulsive disorders 54 pharmacological approaches 54 carotid atherosclerosis 54 Restless Legs Syndrome RLS 54 severe exacerbations 54 Prefrontal 54 flutamide 54 EFFEXOR XR 54 primary biliary cirrhosis